- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Fetuin A significantly decreased in patients with calcific aortic valve disease
Pakistan: A recent meta-analysis published in Atherosclerosis Plus has shown a significant reduction in fetuin-A in patients with known calcific aortic valve disease (CAVD).
The research, however, revealed no association between fetuin-A and calcific aortic valve disease in kidney disease patients. The investigator Muhammad Omar Larik from Dow International Medical College in Karachi, Pakistan, suggest the need for further research to arrive at a robust conclusion regarding fetuin-A use as a diagnostic biomarker for calcific aortic valve disease.
Calcific aortic valve disease is a common valvular disease that is particularly prevalent within the older age groups. The potential use of biomarkers in diagnosing and assessing CAVD severity in supplementation with imaging techniques has recently gained momentum within the field of cardiovascular medicine. Therefore, Dr. Omar Larik performed a meta-analysis to assess the association between the fetuin-A levels and the presence of CAVD.
For this purpose, online databases were searched from inception to April 2023. The Newcastle-Ottawa scale was utilized for bias assessment to determine the quality of the included studies. The initial search revealed fourteen potentially relevant studies. Nine studies (including 3,280 patients with CAVD and 7,505 patients as controls) were selected after a comprehensive full-text screening.
The researchers reported the following findings:
- A total of 3,280 patients with CAVD and 7,505 patients as control were included in the analysis, resulting in the pooling of 10,785 patients in this meta-analysis.
- It was observed that the circulating levels of fetuin-A were significantly lowered in patients with CAVD (SMD: -0.20).
- The analysis revealed that fetuin-A levels had no significant association with CAVD in patients suffering from kidney disease (SMD: 0.20).
"While initial results showed the potential effectiveness," the study stated, "there is a need for further research is essential to arrive at a robust conclusion regarding fetuin-A use as a diagnostic biomarker for calcific aortic valve disease."
Limitations include the unadjusted data that may account for some inconsistencies, as populations of certain studies were subject to a variation of comorbidities when compared to other studies, such as the presence of diabetes mellitus, hypertension, or smoking history. Also, the mata-analysis was performed exclusively using observation studies accounting for an increased level of heterogeneity.
Reference:
Larik, M. O. (2023). Fetuin-A levels in association with calcific aortic valve disease: A meta-analysis. Atherosclerosis Plus, 54, 27-29. https://doi.org/10.1016/j.athplu.2023.09.004
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751